Physician

Syed Mustafa, MD

According to 2025 Medicare claims, Syed Mustafa, MD (NPI: 1326393885) practices pulmonary disease in the Hot Springs, AR market, with the plurality of this provider's patient population coming from Garland, AR. This provider's primary affiliated billing organization is CHI ST. VINCENT MEDICAL GROUP HOT SPRINGS (NPI: 1831387117; TIN: 261125131) and primary practice location at 71913-6406. Mustafa is affiliated with the CommonSpirit ACO I (ACO ID: A2164), Mercy Health ACO, LLC (ACO ID: A2616), and AdvantagePoint Health Alliance - Hot Springs, LLC (ACO ID: A5037), participating under the MSSP model.

Mustafa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 896 traditional Medicare patients, billed 3,538 HCPCS/CPT codes, and received $286,819 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,154 prescription claims across 266 beneficiaries totaling $528,609 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 431 claims. Open Payments data shows 62 records totaling $1,499. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $114,153 and ending at $286,819. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $12,231 to $528,609. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,363 to $67,575.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	494	1,689	$114,153
2020	1,005	4,191	$354,164
2021	921	3,546	$279,199
2022	909	2,576	$194,915
2023	859	2,692	$215,972
2024	896	3,538	$286,819

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	20	74	$12,231
2017	26	156	$28,548
2018	12	74	$14,010
2019	103	360	$142,579
2020	114	590	$368,114
2021	68	270	$193,780
2022	117	375	$191,846
2023	145	412	$188,168
2024	266	1,154	$528,609

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	44	$1,830
2020	41	488	$45,023
2021	15	395	$37,411
2022	12	266	$48,403
2023	N/R	188	$77,693
2024	44	431	$72,725

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	295	812	$152
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	171	328	$85
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	200	255	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	261	639	$57
94729	Test to examine how well the lungs exchange gases	142	143	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	157	5,460	$117,050
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	113	3,630	$76,778
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	81	2,730	$41,319
Nucala	Mepolizumab	11	308	$39,158
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	27	1,338	$21,182

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	49	$46,788
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	18	114	$10,778
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	12	$9,125
E1392	Portable oxygen concentrator, rental	Y	N/R	70	$2,734
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	26	$1,113

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$1,499	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Syed Mustafa, MD?

Tedicare shows public-source Medicare data for Syed Mustafa, MD (NPI 1326393885), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Syed Mustafa, MD have ACO affiliation data?

Syed Mustafa, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), Mercy Health ACO, LLC (MSSP, ACO ID A2616), and AdvantagePoint Health Alliance - Hot Springs, LLC (MSSP, ACO ID A5037).

What billing organization is linked to Syed Mustafa, MD?

Syed Mustafa, MD is linked to CHI ST. VINCENT MEDICAL GROUP HOT SPRINGS (billing NPI 1831387117) in the available physician profile data.

Does Syed Mustafa, MD have Open Payments data?

Syed Mustafa, MD has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.